CON Stock Forecast 2025-2026
Distance to CON Price Targets
CON Price Momentum
10 Quality Stocks Worth Considering Now
Researching Concentra (CON) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on CON and similar high-potential opportunities.
Latest CON Stock Price Targets & Analyst Predictions
Based on our analysis of 8 Wall Street analysts, CON has a bullish consensus with a median price target of $28.50 (ranging from $25.00 to $30.00). The overall analyst rating is Strong Buy (9.3/10). Currently trading at $21.47, the median forecast implies a 32.7% upside. This outlook is supported by 8 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Lisa Gill at JP Morgan, projecting a 39.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CON Analyst Ratings
CON Price Target Range
Latest CON Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CON.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 19, 2025 | JP Morgan | Lisa Gill | Overweight | Maintains | $30.00 |
| Mar 12, 2025 | Wells Fargo | Overweight | Maintains | $25.00 | |
| Jan 23, 2025 | RBC Capital | Ben Hendrix | Outperform | Reiterates | $30.00 |
| Jan 23, 2025 | B of A Securities | Joanna Gajuk | Buy | Maintains | $25.00 |
| Dec 16, 2024 | B of A Securities | Buy | Upgrade | $0.00 | |
| Nov 4, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $30.00 |
| Oct 7, 2024 | B of A Securities | Joanna Gajuk | Neutral | Downgrade | $24.00 |
| Aug 20, 2024 | RBC Capital | Ben Hendrix | Outperform | Initiates | $33.00 |
| Aug 19, 2024 | Wells Fargo | Overweight | Initiates | $27.00 | |
| Aug 19, 2024 | B of A Securities | Joanna Gajuk | Buy | Initiates | $30.50 |
| Aug 19, 2024 | Deutsche Bank | Justin Bowers | Buy | Initiates | $29.00 |
| Aug 19, 2024 | Goldman Sachs | Jamie Perse | Buy | Initiates | $32.00 |
| Aug 19, 2024 | JP Morgan | Lisa Gill | Overweight | Initiates | $29.00 |
| Aug 19, 2024 | Mizuho | Ann Hynes | Outperform | Initiates | $28.00 |
| Aug 19, 2024 | Truist Securities | David Macdonald | Buy | Initiates | $29.00 |
Concentra Group Holdings Inc. (CON) Competitors
The following stocks are similar to Concentra based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Concentra Group Holdings Inc. (CON) Financial Data
Concentra Group Holdings Inc. has a market capitalization of $2.71B with a P/E ratio of 14.5x. The company generates $1.90B in trailing twelve-month revenue with a 8.8% profit margin.
Revenue growth is +5.5% quarter-over-quarter, while maintaining an operating margin of +12.9% and return on equity of +23.3%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Concentra Group Holdings Inc. (CON) Business Model
About Concentra Group Holdings Inc.
Provides healthcare and occupational health services.
Concentra Group Holdings Inc. generates revenue by offering a variety of medical services, including occupational medicine, urgent care, and physical therapy, to a diverse client base consisting of corporations, small businesses, and government entities. The company operates an extensive network of medical centers and on-site clinics aimed at enhancing workforce health and productivity.
As a subsidiary of Select Medical Holdings Corporation, Concentra plays a vital role in reducing workplace injuries and managing employee health, particularly in industries like manufacturing, transportation, and construction. The company is committed to providing convenient healthcare solutions and adapting to the evolving demands of the healthcare landscape.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
8,758
CEO
Mr. William Keith Newton
Country
United States
IPO Year
N/A
Website
www.concentra.comConcentra Group Holdings Inc. (CON) Latest News & Analysis
Concentra Expands to Katy, Texas
3 days agoConcentra has opened a new medical center in Katy, Texas, responding to customer demand. The center is located at 25805 Katy Freeway, Suite 600.
Concentra's expansion into Katy, Texas, signals growth potential and increased market presence, which could enhance revenue and profitability, positively impacting investor sentiment.
Investors are comparing Concentra Group (CON) and Medpace (MEDP) as potential value opportunities in the Medical Services sector.
The comparison between Concentra Group and Medpace highlights potential value opportunities, influencing investment decisions in the Medical Services sector.
Best Momentum Stock to Buy for March 21st
6 days agoRWEOY, ASLE, and CON received a Zacks Rank #1 (Strong Buy) rating on March 21, 2025, indicating strong momentum for these stocks.
RWEOY, ASLE, and CON receiving a Zacks Rank #1 indicates strong growth potential, attracting investor interest and likely leading to increased stock price momentum.
Concentra (CON) is currently oversold, suggesting potential for a trend reversal, supported by strong analyst consensus on raised earnings estimates.
Concentra's oversold status and consensus among analysts for higher earnings estimates suggest potential for a price rebound, signaling a buying opportunity.
Concentra Expands to Waukegan, Illinois
9 days agoConcentra has opened a new medical center in Waukegan, Illinois, aimed at improving occupational health services for local employers and employees.
The opening of Concentra's new medical center enhances market presence and access to care, potentially increasing revenue and market share, which can positively influence stock performance.
Concentra has acquired assets from Physicians Health Center and OM Management, rebranding three locations in Florida as Concentra facilities.
Concentra's acquisition expands its footprint in Florida, enhancing its market position in occupational medicine, potentially leading to increased revenue and market share.
Frequently Asked Questions About CON Stock
What is Concentra Group Holdings Inc.'s (CON) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, Concentra Group Holdings Inc. (CON) has a median price target of $28.50. The highest price target is $30.00 and the lowest is $25.00.
Is CON stock a good investment in 2025?
According to current analyst ratings, CON has 8 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $21.47. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CON stock?
Wall Street analysts predict CON stock could reach $28.50 in the next 12 months. This represents a 32.7% increase from the current price of $21.47. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Concentra Group Holdings Inc.'s business model?
Concentra Group Holdings Inc. generates revenue by offering a variety of medical services, including occupational medicine, urgent care, and physical therapy, to a diverse client base consisting of corporations, small businesses, and government entities. The company operates an extensive network of medical centers and on-site clinics aimed at enhancing workforce health and productivity.
What is the highest forecasted price for CON Concentra Group Holdings Inc.?
The highest price target for CON is $30.00 from Lisa Gill at JP Morgan, which represents a 39.7% increase from the current price of $21.47.
What is the lowest forecasted price for CON Concentra Group Holdings Inc.?
Price targets from Wall Street analysts for CON are not currently available. The stock is trading at $21.47.
What is the overall CON consensus from analysts for Concentra Group Holdings Inc.?
The overall analyst consensus for CON is bullish. Out of 8 Wall Street analysts, 8 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $28.50.
How accurate are CON stock price projections?
Stock price projections, including those for Concentra Group Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
